Corporate
Mar. 12, 2011
Biotech Executives Face Tougher Penalties
Federal prosecutors pursuing biotechnology executives are getting a bigger stick to beat back health care fraud in the form of higher criminal penalties in sentencing guidelines mandated by the Patient Protection and Affordable Care Act.
Daily Journal Staff Writer
SAN DIEGO - Federal prosecutors charging biotechnology executives for wrongdoing are getting a bigger stick to beat back health care fraud in the form of higher criminal penalties.
Last year's Patient Protection and Affordable Care Act mandated new sentencing guidelines for health care fraud, raising the stakes just as the U.S. Department of Justice and U.S. Food and Drug Administration are stepp...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In